Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Pierce

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Biomechanics|March 21, 2017
Rupture risk in abdominal aortic aneurysms: A realistic assessment of the explicit GPU approachV Strbac, D M Pierce, B Rodriguez-Vila, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjectsA Allen, C C Asgill, D M Pierce, et al.
Computer Methods in Biomechanics and Biomedical Engineering|October 12, 2017
Automated hexahedral meshing of knee cartilage structures - application to data from the osteoarthritis initiativeB Rodriguez-Vila, P Sánchez-González, I Oropesa, et al.
Journal of the Mechanical Behavior of Biomedical Materials|December 11, 2021
Magnetic Resonance Imaging-based biomechanical simulation of cartilage: A systematic reviewS M Seyedpour, S Nafisi, M Nabati, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1984
The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteersP S Dowell, D M Pierce, R A Franklin, et al.
British Journal of Clinical Pharmacology|November 1, 1982
Routes of meptazinol conjugation in the neonateP S Dowell, D M Pierce, R A Franklin, et al.
Human Toxicology|May 1, 1989
Pharmacokinetic interaction between indoramin and ethanolS M Abrams, D M Pierce, A Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonistJ W Upward, B D Arnold, C Link, et al.
Thrombosis Research|May 8, 2012
Remodeling of intramural thrombus and collagen in an Ang-II infusion ApoE-/- model of dissecting aortic aneurysmsA J Schriefl, M J Collins, D M Pierce, et al.
European Journal of Clinical Pharmacology|January 1, 1995
The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteersA Allen, P Crome, C C Davie, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Biomechanics|March 21, 2017
Rupture risk in abdominal aortic aneurysms: A realistic assessment of the explicit GPU approachV Strbac, D M Pierce, B Rodriguez-Vila, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjectsA Allen, C C Asgill, D M Pierce, et al.
Computer Methods in Biomechanics and Biomedical Engineering|October 12, 2017
Automated hexahedral meshing of knee cartilage structures - application to data from the osteoarthritis initiativeB Rodriguez-Vila, P Sánchez-González, I Oropesa, et al.
Journal of the Mechanical Behavior of Biomedical Materials|December 11, 2021
Magnetic Resonance Imaging-based biomechanical simulation of cartilage: A systematic reviewS M Seyedpour, S Nafisi, M Nabati, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1984
The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteersP S Dowell, D M Pierce, R A Franklin, et al.
British Journal of Clinical Pharmacology|November 1, 1982
Routes of meptazinol conjugation in the neonateP S Dowell, D M Pierce, R A Franklin, et al.
Human Toxicology|May 1, 1989
Pharmacokinetic interaction between indoramin and ethanolS M Abrams, D M Pierce, A Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonistJ W Upward, B D Arnold, C Link, et al.
Thrombosis Research|May 8, 2012
Remodeling of intramural thrombus and collagen in an Ang-II infusion ApoE-/- model of dissecting aortic aneurysmsA J Schriefl, M J Collins, D M Pierce, et al.
European Journal of Clinical Pharmacology|January 1, 1995
The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteersA Allen, P Crome, C C Davie, et al.
Pageof 5